Table 3

Effect of PJ intake on the incidence rate, rate ratio and attributable risk of first and second CVD events
CV Events Group Incidence rate Rate ratio P.V (95% CI) Attribute risk
First event PJ

<a onClick="popup('http://www.nutritionj.com/content/13/1/18/mathml/M1','MathML',630,470);return false;" target="_blank" href="http://www.nutritionj.com/content/13/1/18/mathml/M1">View MathML</a>

0.61 0.30 (0.25-1.5)

<a onClick="popup('http://www.nutritionj.com/content/13/1/18/mathml/M2','MathML',630,470);return false;" target="_blank" href="http://www.nutritionj.com/content/13/1/18/mathml/M2">View MathML</a>

Placebo

<a onClick="popup('http://www.nutritionj.com/content/13/1/18/mathml/M3','MathML',630,470);return false;" target="_blank" href="http://www.nutritionj.com/content/13/1/18/mathml/M3">View MathML</a>

Second event PJ

<a onClick="popup('http://www.nutritionj.com/content/13/1/18/mathml/M4','MathML',630,470);return false;" target="_blank" href="http://www.nutritionj.com/content/13/1/18/mathml/M4">View MathML</a>

0.54 0.55 (0.08-3.9)

<a onClick="popup('http://www.nutritionj.com/content/13/1/18/mathml/M5','MathML',630,470);return false;" target="_blank" href="http://www.nutritionj.com/content/13/1/18/mathml/M5">View MathML</a>

Placebo

<a onClick="popup('http://www.nutritionj.com/content/13/1/18/mathml/M6','MathML',630,470);return false;" target="_blank" href="http://www.nutritionj.com/content/13/1/18/mathml/M6">View MathML</a>

Shema-Didi et al.

Shema-Didi et al. Nutrition Journal 2014 13:18   doi:10.1186/1475-2891-13-18

Open Data